Company Announcement no. 18/2010

To: NASDAQ OMX Copenhagen A/S Hørsholm, Denmark, October 25, 2010


LifeCycle Pharma A/S - Passing of Extraordinary General Meeting

Hørsholm, Denmark, October 25, 2010; LifeCycle Pharma A/S (OMX: LCP) (the
“Company”) today held an extraordinary general meeting at Søhuset,
Venlighedsvej 10, DK-2970 Hørsholm.

At the general meeting, the proposal to increase the existing authorization for
the board of directors to issue shares from nominal DKK 1,012,229 to nominal
DKK 475,000,000 and to extend the authorization from 1 July 2011 until 24
October 2015 was adopted (article 9 of the articles of association). Further,
the proposal to increase the existing authorisation to the board of directors
to issue warrants from an authorisation to issue warrants that confer a right
to subscribe nominal DKK 2,478,000 shares to an authorisation to issue warrants
that confer a right to subscribe nominal DKK 44,000,000 shares in the Company -
limited, however, to 10% of the Company's registered share capital was adopted
(article 8 of the articles of association). The chairman of the general meeting
was authorised to register the resolutions passed by the general meeting with
the Danish Commerce and Companies Agency.

For more information, please contact:

LifeCycle Pharma A/S

William J. Polvino Johnny Stilou
President and CEO CFO
Mobile: +1 917 647 9107 Mobile: +45 20 55 38 52
Email: [email protected] Email: [email protected]

passing of extraordinary general meeting_25102010.pdf